Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MYGN | Common Stock | Award | $15.5K | +1.12K | +0.37% | $13.83 | 302K | Nov 30, 2024 | Direct | F1 |
Id | Content |
---|---|
F1 | These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |